Clinical trials are critically important to the development of new therapies for the treatment of amyloidosis. They are a part of the scientific research process and are essential to developing better treatments. They can also provide insight about the disease process.
Clinical trials, also called clinical studies, are research trials with human volunteers. The goal is to answer questions about new potential drugs, or new ways of using existing therapies in order to see how well they work. Many trials face delays or never get off the ground because of a lack of volunteers. Without patient volunteers, the research is limited.
This is a call to action. To find out more about clinical trials, click on the link. Link to clinicaltrials.gov